from a sale base... of less than $1m.
They’re running at $50m expenses a year, more capital raises and more capital raises.
- Forums
- ASX - By Stock
- AVH
- Ann: Appendix 4E and Preliminary Final Report
AVH
avita medical inc.
Add to My Watchlist
0.89%
!
$1.68

Ann: Appendix 4E and Preliminary Final Report, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.68 |
Change
-0.015(0.89%) |
Mkt cap ! $117.5M |
Open | High | Low | Value | Volume |
$1.71 | $1.73 | $1.67 | $250.4K | 147.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1165 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.69 | 1877 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 943 | 1.675 |
1 | 1000 | 1.670 |
2 | 4162 | 1.665 |
1 | 9000 | 1.660 |
3 | 13200 | 1.650 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 4303 | 6 |
1.685 | 755 | 1 |
1.695 | 5503 | 2 |
1.700 | 3300 | 2 |
1.720 | 61933 | 2 |
Last trade - 11.01am 07/07/2025 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online